Acorah Software Products - Accounts Production 16.4.675 false true 31 March 2024 1 April 2023 false 1 April 2024 31 March 2025 31 March 2025 05516038 Dr M R Bermingham Dr B S Cooner Dr R V Heatherley Dr B S Cooner iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 05516038 2024-03-31 05516038 2025-03-31 05516038 2024-04-01 2025-03-31 05516038 frs-core:CurrentFinancialInstruments 2025-03-31 05516038 frs-core:ShareCapital 2025-03-31 05516038 frs-core:RetainedEarningsAccumulatedLosses 2025-03-31 05516038 frs-bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 05516038 frs-bus:FilletedAccounts 2024-04-01 2025-03-31 05516038 frs-bus:SmallEntities 2024-04-01 2025-03-31 05516038 frs-bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 05516038 frs-bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 05516038 frs-bus:Director1 2024-04-01 2025-03-31 05516038 frs-bus:Director2 2024-04-01 2025-03-31 05516038 frs-bus:Director3 2024-04-01 2025-03-31 05516038 frs-bus:CompanySecretary1 2024-04-01 2025-03-31 05516038 frs-countries:EnglandWales 2024-04-01 2025-03-31 05516038 2023-03-31 05516038 2024-03-31 05516038 2023-04-01 2024-03-31 05516038 frs-core:CurrentFinancialInstruments 2024-03-31 05516038 frs-core:ShareCapital 2024-03-31 05516038 frs-core:RetainedEarningsAccumulatedLosses 2024-03-31
Registered number: 05516038
Gnosall Medical Limited
Unaudited Financial Statements
For The Year Ended 31 March 2025
Deans
Gibson House Hurricane Close
Stafford
Staffordshire
ST16 1GZ
Contents
Page
Balance Sheet 1
Notes to the Financial Statements 2—3
Page 1
Balance Sheet
Registered number: 05516038
2025 2024
Notes £ £ £ £
CURRENT ASSETS
Debtors 4 68,257 63,474
Cash at bank and in hand 8,196 15,032
76,453 78,506
Creditors: Amounts Falling Due Within One Year 5 (3,618 ) (2,013 )
NET CURRENT ASSETS (LIABILITIES) 72,835 76,493
TOTAL ASSETS LESS CURRENT LIABILITIES 72,835 76,493
NET ASSETS 72,835 76,493
CAPITAL AND RESERVES
Called up share capital 6 140 140
Profit and Loss Account 72,695 76,353
SHAREHOLDERS' FUNDS 72,835 76,493
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Dr B S Cooner
Director
11 July 2025
The notes on pages 2 to 3 form part of these financial statements.
Page 1
Page 2
Notes to the Financial Statements
1. General Information
Gnosall Medical Limited is a private company, limited by shares, registered in England & Wales.  The company's registered number and registered office address can be found on the Company Information page.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of section 1a "Small Entities" and the Companies Act 2006.  The financial statements have been prepared under the historical cost convention.
The financial statements are presented in sterling which is the functional currency of the company and rounded to the nearest £.
The significant accounting policies applied in the preparation of these financial statements are set out below.  These policies have been consistently applied to all years presented unless otherwise stated.
2.2. Taxation
Taxation for the year comprises current and deferred tax.  Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.  
Current or deferred taxation assets and liabilities are not discounted.
Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.
Timing differences arise from the inclusion of income and expenses in tax assesments in periods different from those in which they aare recognised in financial statements.  Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.
Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.
2.3. Debtors and creditors receivable / payable within one year
Debtors and creditors with no stated interest rate and receivable or payable within one year are recorded at transaction price.  Any losses arising from impairment are recognised in the profit and loss account in other administrative expenses.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 3 (2024: 3)
3 3
4. Debtors
2025 2024
£ £
Due within one year
Funds due from Gnosall Surgery 68,257 63,474
5. Creditors: Amounts Falling Due Within One Year
2025 2024
£ £
Accruals and deferred income 3,618 2,013
Page 2
Page 3
6. Share Capital
2025 2024
£ £
Allotted, Called up and fully paid 140 140
Page 3